文献速递心脑血管急症重症综合管理与镇静镇痛

外伤性颅内高压脑室外引流术的疗效及成功预测因素:一项回顾性多中心队列研究

Efficacy and Predictors of Success of External Ventricular Drainage for the Management of Traumatic Intracranial Hypertension: A Retrospective Multicenter Cohort Study.
PubMed 文献 · Neurocrit Care · 2025-10-09
一句话结论在最大药物治疗仍颅内高压的颅脑外伤患者中,脑室外引流术使50%患者持续控制颅内压,基线严重程度影响成功率。

这项在法国9个区域创伤中心开展的多中心回顾性队列研究(2019年1月1日至2022年12月31日),纳入176例最大药物治疗后仍颅内高压并接受脑室外引流术的颅脑外伤患者。脑室外引流术成功定义为有效控制颅内压、避免使用任何三线治疗或因难治性颅内高压和脑损伤严重程度而避免放弃生命维持治疗决策,88例(50%)达到持续控制。多因素分析显示,联合镇静药物、脑室外引流术前CT基底池消失和胸部创伤严重程度与脑室外引流术成功可能性低相关,而入院超过24小时后放置脑室外引流术与成功独立相关。并发症少见:医疗相关脑室炎3%,脑室外引流路径上显著血肿(>1 cm)3%。

要点

  • 在最大药物治疗后仍颅内高压的颅脑外伤患者中,脑室外引流术使50%(88/176)患者达到持续颅内压控制。
  • 脑室外引流术前CT显示基底池消失与脑室外引流术成功可能性低独立相关(OR 0.07;95%CI 0.00-0.39;p=0.013)。
  • 使用联合镇静药物与脑室外引流术成功可能性低独立相关(OR 0.28;95%CI 0.12-0.62;p=0.002)。
  • 胸部创伤严重程度与脑室外引流术成功可能性低独立相关(OR 0.79;95%CI 0.64-0.99;p=0.039)。
  • 入院超过24小时后放置脑室外引流术与成功独立相关(OR 3.07;95%CI 1.41-7.01;p=0.006)。

适用人群与场景

  • 法国9个区域创伤中心、参与Traumabase登记库的颅脑外伤患者,最大药物治疗后仍存在颅内高压并接受脑室外引流术治疗。

诊断标准与关键阈值

  • 脑室外引流术成功定义为有效控制颅内压,避免使用任何三线治疗,或因难治性颅内高压和脑损伤严重程度而避免放弃生命维持治疗决策。

研究设计与关键结果

  • 多中心回顾性队列研究,纳入176例颅脑外伤后最大药物治疗仍颅内高压并接受脑室外引流术的患者,88例(50%)达到持续颅内压控制。
  • 并发症:医疗相关脑室炎3%,脑室外引流路径上显著血肿(>1 cm)3%。
  • 多因素分析:联合镇静药物与脑室外引流术成功可能性低相关(OR 0.28;95%CI 0.12-0.62;p=0.002);脑室外引流术前CT基底池消失与成功可能性低相关(OR 0.07;95%CI 0.00-0.39;p=0.013);胸部创伤严重程度与成功可能性低相关(OR 0.79;95%CI 0.64-0.99;p=0.039);入院超过24小时后放置脑室外引流术与成功独立相关(OR 3.07;95%CI 1.41-7.01;p=0.006)。

证据类型、等级与局限

  • 证据类型:多中心回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于最大药物治疗后仍颅内高压的颅脑外伤患者,脑室外引流术可在约半数病例中有效控制颅内压,且并发症少。
  • 联合镇静药物、脑室外引流术前CT基底池消失、胸部创伤严重程度较高可能提示脑室外引流术成功可能性较低,临床决策时可结合这些因素评估。
  • 入院超过24小时后放置脑室外引流术与成功独立相关,早期放置可能并非更优,需结合临床情况个体化判断。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: External ventricular drainage (EVD) is commonly used to manage elevated intracranial pressure (ICP) following traumatic brain injury (TBI). However, evidence supporting its effectiveness in this context remains limited. This study aimed to evaluate the effectiveness of EVD in controlling elevated ICP and to identify clinical and radiological factors associated with its success.

METHODS: A multicenter retrospective cohort study was conducted between January 1, 2019, and December 31, 2022, across nine regional trauma centers in France participating in the Traumabase registry. All patients with TBI with intracranial hypertension despite maximal medical therapy and treated with EVD were included. EVD success was defined as an effective control of ICP avoiding the use of any third-tier therapy or avoiding a decision to withdraw life-sustaining treatment due to both refractory intracranial hypertension and severity of brain injury lesions.

RESULTS: A cohort of 176 patients with TBI treated with EVD was included. Among these patients, 88 (50%) achieved sustained control of ICP after EVD, with few complications reported (health care-associated ventriculitis: 3%, significant hematoma [> 1 cm] on EVD path: 3%). In the multivariate analysis, sedation with a combination of sedative drugs (odds ratio [OR] 0.28; 95% confidence interval [CI] 0.12-0.62, p = 0.002), obliterated basal cisterns on the brain computed tomography scan prior to EVD placement (OR 0.07; 95% CI 0.00-0.39, p = 0.013), and severity of chest trauma (OR 0.79; 95% CI 0.64-0.99, p = 0.039) were factors associated with poor likelihood of EVD success. Conversely, EVD placement occurring more than 24 h after admission was independently associated with success (OR 3.07; 95% CI 1.41-7.01, p = 0.006).

CONCLUSIONS: In this multicenter cohort of patients with TBI with refractory intracranial hypertension, EVD effectively controlled ICP in half of the cases. The effectiveness of EVD appears to depend on clinical and radiological markers of severity of traumatic intracranial hypertension.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Moyer JD, Cohen B, Werner M, et al. Efficacy and Predictors of Success of External Ventricular Drainage for the Management of Traumatic Intracranial Hypertension: A Retrospective Multicenter Cohort Study. Neurocrit Care. 2025. PMID: 41068446. doi:10.1007/s12028-025-02394-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。